| |
| |
|
| Insider
Information: |
Stampacchia Otello |
| Relationship: |
Director |
| City: |
George Town, Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
17,297,599 |
|
|
Indirect Shares
|
21,254,784 |
|
|
| Direct
Value |
$91,436,444 |
|
|
|
Indirect Value
|
$119,391,733 |
|
|
| Total
Shares |
38,552,383 |
|
|
| Total
Value |
$210,828,177 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 78.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gossamer Bio Inc |
GOSS |
Former director., 10% ... |
2019-09-18 |
6,737,023 |
2019-02-12 |
6,953,416 |
Premium* |
|
|
Morphic Holding, Inc. |
MORF |
Director |
2021-04-30 |
2,068,913 |
2019-07-01 |
2,969,582 |
Premium* |
|
|
Replimune Group Inc |
REPL |
10% Owner |
2022-03-16 |
4,673,380 |
2022-03-14 |
4,763,380 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
3,818,283 |
2020-10-14 |
3,818,283 |
Premium* |
|
|
Omega Alpha Spac |
OMEG |
Chief Executive Office... |
|
0 |
2021-01-11 |
501,000 |
Premium* |
|
|
Ikena Oncology, Inc. |
IKNA |
Director |
2021-03-30 |
0 |
2021-03-30 |
2,249,123 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRON |
Kronos Bio, Inc. |
Director |
– • • |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
19,451 |
|
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • • |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,451 |
|
- |
|
| OMEG |
Omega Alpha Spac |
Chief Executive Officer |
• • • |
2021-01-11 |
4 |
B |
$10.00 |
$5,010,000 |
I/I |
501,000 |
501,000 |
2.64 |
- |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,799,123 |
1,799,123 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-30 |
4 |
AS |
$54.26 |
$523,075 |
D/D |
(9,487) |
2,068,913 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-29 |
4 |
AS |
$53.37 |
$414,587 |
D/D |
(7,671) |
2,078,400 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-28 |
4 |
AS |
$55.36 |
$187,536 |
D/D |
(3,366) |
2,086,071 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-27 |
4 |
AS |
$54.60 |
$405,718 |
D/D |
(7,338) |
2,089,437 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-26 |
4 |
AS |
$55.54 |
$290,993 |
D/D |
(5,146) |
2,096,775 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-23 |
4 |
AS |
$55.11 |
$482,775 |
D/D |
(8,672) |
2,101,921 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-22 |
4 |
AS |
$56.34 |
$704,075 |
D/D |
(12,235) |
2,110,593 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-21 |
4 |
AS |
$53.76 |
$425,186 |
D/D |
(7,552) |
2,122,828 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-20 |
4 |
AS |
$54.07 |
$533,162 |
D/D |
(9,793) |
2,130,380 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-19 |
4 |
AS |
$54.06 |
$437,344 |
D/D |
(8,081) |
2,140,173 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-16 |
4 |
AS |
$54.37 |
$359,631 |
D/D |
(6,565) |
2,148,254 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-15 |
4 |
AS |
$55.16 |
$627,490 |
D/D |
(11,181) |
2,154,819 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-14 |
4 |
AS |
$55.88 |
$801,371 |
D/D |
(13,932) |
2,166,000 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-13 |
4 |
AS |
$56.70 |
$402,136 |
D/D |
(7,004) |
2,179,932 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-12 |
4 |
AS |
$56.84 |
$835,784 |
D/D |
(14,592) |
2,186,936 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-09 |
4 |
AS |
$58.13 |
$603,260 |
D/D |
(10,220) |
2,201,528 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-08 |
4 |
AS |
$60.48 |
$926,719 |
D/D |
(15,236) |
2,211,748 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-07 |
4 |
AS |
$60.51 |
$695,365 |
D/D |
(11,449) |
2,226,984 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-06 |
4 |
AS |
$60.93 |
$665,011 |
D/D |
(10,881) |
2,238,433 |
0 |
% |
|
| IKNA |
Ikena Oncology, Inc. |
Director |
– • – |
2021-03-30 |
4 |
A |
$16.00 |
$7,200,000 |
I/I |
450,000 |
2,249,123 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-05 |
4 |
AS |
$61.05 |
$592,679 |
D/D |
(9,543) |
2,249,314 |
0 |
% |
|
119 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
